vs
Side-by-side financial comparison of NexPoint Real Estate Finance, Inc. (NREF) and uniQure N.V. (QURE). Click either name above to swap in a different company.
NexPoint Real Estate Finance, Inc. is the larger business by last-quarter revenue ($11.1M vs $5.6M, roughly 2.0× uniQure N.V.). On growth, uniQure N.V. posted the faster year-over-year revenue change (6.6% vs -48.8%).
NexPoint Real Estate Finance, Inc. is a US-based commercial real estate finance firm that offers structured financing solutions for multifamily, office, industrial, and hospitality properties. It focuses on originating, managing and servicing a diversified portfolio of mortgage loans and real estate-related investments to deliver stable risk-adjusted returns to stakeholders.
uniQure is a Dutch biopharmaceutical company which makes gene therapies. It has developed several adeno-associated virus gene therapies.
NREF vs QURE — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $11.1M | $5.6M |
| Net Profit | $24.0M | — |
| Gross Margin | — | 92.2% |
| Operating Margin | — | — |
| Net Margin | 216.6% | — |
| Revenue YoY | -48.8% | 6.6% |
| Net Profit YoY | 58.7% | 49.4% |
| EPS (diluted) | $0.47 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $11.1M | $5.6M | ||
| Q3 25 | $12.5M | $3.7M | ||
| Q2 25 | $12.1M | $5.3M | ||
| Q1 25 | $11.5M | $1.6M | ||
| Q4 24 | $21.7M | $5.2M | ||
| Q3 24 | $12.5M | $2.3M | ||
| Q2 24 | $6.7M | $11.1M | ||
| Q1 24 | $-12.8M | $8.5M |
| Q4 25 | $24.0M | — | ||
| Q3 25 | $50.9M | $-80.5M | ||
| Q2 25 | $22.3M | $-37.7M | ||
| Q1 25 | $26.0M | $-43.6M | ||
| Q4 24 | $15.2M | — | ||
| Q3 24 | $23.3M | $-44.4M | ||
| Q2 24 | $12.1M | $-56.3M | ||
| Q1 24 | $-14.6M | $-65.6M |
| Q4 25 | — | 92.2% | ||
| Q3 25 | — | 89.2% | ||
| Q2 25 | — | 87.5% | ||
| Q1 25 | — | 87.4% | ||
| Q4 24 | — | 88.1% | ||
| Q3 24 | — | 88.5% | ||
| Q2 24 | — | 97.9% | ||
| Q1 24 | — | 98.2% |
| Q4 25 | — | — | ||
| Q3 25 | — | -1379.0% | ||
| Q2 25 | — | -833.6% | ||
| Q1 25 | — | -2510.0% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | -1759.0% | ||
| Q2 24 | — | -395.6% | ||
| Q1 24 | — | -639.1% |
| Q4 25 | 216.6% | — | ||
| Q3 25 | 407.0% | -2175.9% | ||
| Q2 25 | 184.5% | -716.8% | ||
| Q1 25 | 225.6% | -2784.7% | ||
| Q4 24 | 69.9% | — | ||
| Q3 24 | 186.4% | -1940.4% | ||
| Q2 24 | 179.7% | -506.0% | ||
| Q1 24 | 114.3% | -773.3% |
| Q4 25 | $0.47 | — | ||
| Q3 25 | $1.14 | $-1.38 | ||
| Q2 25 | $0.54 | $-0.69 | ||
| Q1 25 | $0.70 | $-0.82 | ||
| Q4 24 | $0.71 | — | ||
| Q3 24 | $0.74 | $-0.91 | ||
| Q2 24 | $0.40 | $-1.16 | ||
| Q1 24 | $-0.83 | $-1.36 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $31.1M | $80.2M |
| Total DebtLower is stronger | $771.2M | $71.9M |
| Stockholders' EquityBook value | $388.0M | $198.9M |
| Total Assets | $5.3B | $824.9M |
| Debt / EquityLower = less leverage | 1.99× | 0.36× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $31.1M | $80.2M | ||
| Q3 25 | $17.9M | $597.1M | ||
| Q2 25 | $9.1M | $253.8M | ||
| Q1 25 | $19.2M | $217.2M | ||
| Q4 24 | $3.9M | $158.9M | ||
| Q3 24 | $34.7M | $251.6M | ||
| Q2 24 | $4.3M | $287.9M | ||
| Q1 24 | $13.5M | $243.1M |
| Q4 25 | $771.2M | $71.9M | ||
| Q3 25 | $720.9M | — | ||
| Q2 25 | $815.6M | — | ||
| Q1 25 | $831.5M | — | ||
| Q4 24 | $799.3M | $66.0M | ||
| Q3 24 | $815.5M | — | ||
| Q2 24 | $861.0M | — | ||
| Q1 24 | $843.3M | — |
| Q4 25 | $388.0M | $198.9M | ||
| Q3 25 | $375.4M | $228.7M | ||
| Q2 25 | $348.2M | $-4.0M | ||
| Q1 25 | $343.7M | $33.7M | ||
| Q4 24 | $336.5M | $-6.8M | ||
| Q3 24 | $335.8M | $55.8M | ||
| Q2 24 | $327.5M | $97.1M | ||
| Q1 24 | $327.1M | $146.8M |
| Q4 25 | $5.3B | $824.9M | ||
| Q3 25 | $5.3B | $888.4M | ||
| Q2 25 | $5.4B | $584.9M | ||
| Q1 25 | $5.4B | $605.4M | ||
| Q4 24 | $5.4B | $556.5M | ||
| Q3 24 | $5.7B | $645.8M | ||
| Q2 24 | $6.6B | $730.8M | ||
| Q1 24 | $7.1B | $770.0M |
| Q4 25 | 1.99× | 0.36× | ||
| Q3 25 | 1.92× | — | ||
| Q2 25 | 2.34× | — | ||
| Q1 25 | 2.42× | — | ||
| Q4 24 | 2.38× | — | ||
| Q3 24 | 2.43× | — | ||
| Q2 24 | 2.63× | — | ||
| Q1 24 | 2.58× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-4.5M | $-178.0M |
| Free Cash FlowOCF − Capex | — | $-178.4M |
| FCF MarginFCF / Revenue | — | -3204.1% |
| Capex IntensityCapex / Revenue | — | 7.9% |
| Cash ConversionOCF / Net Profit | -0.19× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-279.2M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-4.5M | $-178.0M | ||
| Q3 25 | $8.1M | $-16.4M | ||
| Q2 25 | $3.3M | $-39.9M | ||
| Q1 25 | $16.0M | $-44.1M | ||
| Q4 24 | $4.4M | $-182.7M | ||
| Q3 24 | $14.7M | $-36.6M | ||
| Q2 24 | $-7.5M | $-32.7M | ||
| Q1 24 | $17.7M | $-60.6M |
| Q4 25 | — | $-178.4M | ||
| Q3 25 | — | $-16.5M | ||
| Q2 25 | — | $-40.2M | ||
| Q1 25 | — | $-44.2M | ||
| Q4 24 | — | $-186.1M | ||
| Q3 24 | — | $-37.0M | ||
| Q2 24 | — | $-33.3M | ||
| Q1 24 | — | $-62.9M |
| Q4 25 | — | -3204.1% | ||
| Q3 25 | — | -444.9% | ||
| Q2 25 | — | -763.1% | ||
| Q1 25 | — | -2822.3% | ||
| Q4 24 | — | -3564.4% | ||
| Q3 24 | — | -1616.9% | ||
| Q2 24 | — | -299.4% | ||
| Q1 24 | — | -741.5% |
| Q4 25 | — | 7.9% | ||
| Q3 25 | — | 1.8% | ||
| Q2 25 | — | 4.9% | ||
| Q1 25 | — | 8.0% | ||
| Q4 24 | — | 64.5% | ||
| Q3 24 | — | 16.6% | ||
| Q2 24 | — | 5.4% | ||
| Q1 24 | — | 27.6% |
| Q4 25 | -0.19× | — | ||
| Q3 25 | 0.16× | — | ||
| Q2 25 | 0.15× | — | ||
| Q1 25 | 0.62× | — | ||
| Q4 24 | 0.29× | — | ||
| Q3 24 | 0.63× | — | ||
| Q2 24 | -0.62× | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
